Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
20 Jul 2026
Rituximab Supports First-Line Treatment in Pemphigus Foliaceus
A meta-analysis found rituximab achieved complete remission in 75% of patients with pemphigus foliaceus, supporting its use as first-line treatment.
3
Mins
20 Jul 2026
EAACI 2026 Interview: Aspasia Karavelia
The JMA serves as a bridge between early-career professionals and the wider EAACI community. Our goal is not only to provide educational…
5
Mins
20 Jul 2026
ESHRE 2026 Interview: Anis Feki
The central challenge is inequity. Across Europe, access to fertility care still depends too heavily on where people live, on funding…
20 Jul 2026
Memory B Cells Predicted BCG Response in Bladder Cancer
Higher pretreatment memory B cell infiltration and mature tertiary lymphoid structures were associated with improved BCG response and longer recurrence free survival in patients with non muscle invasive bladder cancer.
20 Jul 2026
MHRA Approves Nerandomilast for Pulmonary Fibrosis
The MHRA has approved nerandomilast for adults with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, expanding treatment options in the UK.
20 Jul 2026
Kaposi Sarcoma Relapse Reported Despite HIV Viral Control
Kaposi sarcoma relapse was observed in people living with HIV despite viral suppression, with chemotherapy responses seen in a small prospective cohort.
20 Jul 2026
Belimumab Doubles Apparent Lupus Remission Rates
Modified outcome definitions excluding corticosteroid metrics demonstrate that belimumab significantly improves lupus remission rates compared to placebo.
3
Mins
20 Jul 2026
ESHRE 2026 Interview: Karen Sermon
I think whole genome sequencing is probably the next major step. Once you’re analysing an embryo, it becomes technically possible to look…
19 Jul 2026
Serum REG3α Enhances Ulcerative Colitis Disease Activity Detection
A prospective study suggests the serum REG3α biomarker is associated with clinical and endoscopic activity in ulcerative colitis and may complement C reactive protein testing.
19 Jul 2026
Kaposi Sarcoma Risk in People with HIV Linked to MAVS Gene Variant
A genome-wide association study identified a MAVS gene variant associated with Kaposi sarcoma in people living with HIV, highlighting inherited susceptibility.
←
1
2
3
…
70
71
72
73
74
75
76
…
1,756
1,757
1,758
→
We’ve noticed you’re accessing
from
North/South America.
View
View